AUTL · Autolus Therapeutics plc ADR
United States · RS rating 28 · As of 2026-11-03
| Price | 1.42 USD |
|---|---|
| 1-day change | -0.3% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 19 / 25 / 44 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 25 / 39 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +44.4% |
| Sales growth Q/Q | +14.6% |
| Distance from 52-week high | +44.3% |
| Market cap (USD) | $407.2M |